Home › Trial NCT07590531
AMT-116 in Combination With AK112 in Patients With Lung Cancer
- Trial IDNCT07590531
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorMultitude Therapeutics Inc.
- Enrollment118
- Start date2026-06-29
- ConditionsAdvanced Non-small Cell Lung Cancer (NSCLC)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.